Cellect Biotechnology Ltd.
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Total operating expenses were $22,332,000.

Profit Margin

Cellect Biotechnology Ltd. (NASDAQ:APOP): Profit margin
2016 0 15.31M
2017 0 28.22M
2018 0 0
2019 0 16.80M

APOP Income Statement (2016 – 2019)

2019 2018 2017 2016
Revenue
Revenue
0000
Cost of revenue
0000
Gross profit
0000
Operating exp.
Research and development
12.12M13.51M11.50M8.25M
Selling and marketing
0000
Total operating expenses
22.33M29.24M24.43M15.94M
Operating income
16.80M028.22M15.31M
Other income (expenses), net
0000
Income before tax
16.80M028.22M15.31M
Income tax expense
0000
Net income
16.80M028.22M15.31M
Earnings per share
Basic EPS
0.3201.010.67
Diluted EPS
0.3201.010.67
Data sourceData sourceData sourceData source